CareDx

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CareDx and other ETFs, options, and stocks.

About CDNA

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products.

CEO

John W. Hanna

CEOJohn W. Hanna

Employees

765

Employees765

Headquarters

Brisbane, California

HeadquartersBrisbane, California

Founded

1998

Founded1998

Employees

765

Employees765

CDNA Key Statistics

Market cap

1.35B

Market cap1.35B

Price-Earnings ratio

-169.89

Price-Earnings ratio-169.89

Dividend yield

—

Dividend yield—

Average volume

959.34K

Average volume959.34K

High today

$26.26

High today$26.26

Low today

$23.60

Low today$23.60

Open price

$23.93

Open price$23.93

Volume

2.74M

Volume2.74M

52 Week high

$26.26

52 Week high$26.26

52 Week low

$10.96

52 Week low$10.96

Stock Snapshot

CareDx(CDNA) stock is priced at $26.20, giving the company a market capitalization of 1.35B. It carries a P/E multiple of -169.89.

During the trading session on 2026-06-20, CareDx(CDNA) shares reached a daily high of $26.26 and a low of $23.60. At a current price of $26.20, the stock is +11.0% higher than the low and still -0.2% under the high.

Trading volume for CareDx(CDNA) stock has reached 2.74M, versus its average volume of 959.34K.

Over the past 52 weeks, CareDx(CDNA) stock has traded between a high of $26.26 and a low of $10.96.

CDNA News

Nasdaq 1d

CareDx Moves 11.5% Higher: Will This Strength Last?

CareDx CDNA shares rallied 11.5% in the last trading session to close at $26.18. This move can be attributable to notable volume with a higher number of shares...

Simply Wall St 1d

How New AlloSure Kidney Prognostic Evidence At CareDx Has Changed Its Investment Story - simplywall.st

...

TipRanks 2d

CareDx showcases precision medicine diagnostics at ATC 2026

CareDx (CDNA) announced its participation at the American Transplant Congress 2026, taking place June 20-24 in Boston, Massachusetts. Real-world clinical use an...

Analyst ratings

57%

of 7 ratings

Buy

42.9%

Hold

57.1%

Sell

More CDNA News

TipRanks 4d

CareDx announces second KOAR analysis published in JASN

The company states: “CareDx (CDNA) announced the publication of a new analysis from the Kidney Allograft Outcomes AlloSure Registry, a landmark multi-center stu...

TipRanks 5d

CareDx Shareholders Back Directors, Auditor and Equity Plan

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

People also own

Based on the portfolios of people who own CDNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.